Minnesota Attorney General Keith Ellison says his office has settled with the last of the three largest insulin manufacturers ...

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...

Next up, Tremfya made a triumphant return to the 2024 roundup after falling off the rankings in 2023. The med's return came ...

Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced ...

A longtime pharmaceutical executive laments the woeful state of the industry and calls for new leadership to win back public trust ...

“Samples were sparse, the TV ads were late ... says Alkermes is working to develop an inhaled insulin with partner Eli Lilly, in Indianapolis, that is called AIR Insulin and is currently ...

Clean Science and Technology: The company’s arm Clean Fino-Chem has commenced commercial production of 2,5 ... Lupin: The company announced the acquisition of Huminsulin in India from Eli Lilly and ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of around $720 billion. For a while, it looked like it might be on track to be the first ...

In 2025, Ms. Walker will collaborate with Lilly on certain digital commercial activities. Eli Lilly and Company (NYSE: LLY) today announced positive Phase 2 results for muvalaplin, an ...